# Case Report: Electroanatomic mapping as an early diagnostic tool in arrhythmogenic cardiomyopathy

**Authors:** Jose F. de Melo, Samuel A. Shabtaie, Martin van Zyl, Jeremy D. Collins, Konstantinos C. Siontis

PMC · DOI: 10.3389/fcvm.2024.1392186 · Frontiers in Cardiovascular Medicine · 2024-08-09

## TL;DR

This case report shows how electroanatomic mapping helped diagnose arrhythmogenic cardiomyopathy early, even when imaging results were normal.

## Contribution

The study highlights the potential of electroanatomic mapping as an early diagnostic tool for ACM, which is not currently included in diagnostic criteria.

## Key findings

- Electroanatomic mapping revealed abnormal substrate in a patient with normal imaging results.
- Genetic testing confirmed ACM after EAM suggested RV cardiomyopathy.
- Early electropathic changes may precede structural changes in ACM.

## Abstract

Abnormal substrate on invasive electroanatomic mapping (EAM) correlates with areas of myocardial thinning and fibrofatty replacement in Arrhythmogenic Cardiomyopathy (ACM). However, EAM parameters are absent from all sets of diagnostic criteria for ACM.

A 41-year-old female with no significant family history was referred for evaluation of frequent premature ventricular complexes (PVCs). Twelve-lead ECG showed diffuse low-voltage QRS complexes. Holter monitor showed 28% burden of PVCs with various morphologies consistent with right ventricular (RV) inflow and outflow tract exits. Transthoracic echocardiogram revealed normal biventricular function and dimension. Cardiac magnetic resonance revealed a mildly increased indexed RV end-diastolic volume with normal RV systolic function and no dyssynchrony, akinesia, dyskinesia, or late gadolinium enhancement. Electrophysiologic study demonstrated 2 predominant PVC morphologies that were targeted with ablation, in addition to extensive abnormality with low-voltage and fractionated electrograms in the peri-tricuspid and right ventricular outflow tract free wall regions with septal sparing, suggestive of RV cardiomyopathy. Subsequent genetic testing revealed two pathogenic variants in the desmoplakin and plakophilin-2 genes, confirming the diagnosis of ACM.

Advanced RV electropathy can precede RV structural changes in ACM. Invasive evaluation of the electroanatomic substrate should be considered in select cases even when imaging findings are not diagnostic. Future iterations of ACM guidelines may need to consider EAM substrate as one of the diagnostic criteria. A high index of diagnostic suspicion for ACM should be maintained in patients with multifocal RV ectopy.

## Linked entities

- **Genes:** desmoplakin (putative desmoplakin) [NCBI Gene 951777]

## Full-text entities

- **Genes:** DSP (desmoplakin) [NCBI Gene 1832] {aka DCWHKTA, DP}, PKP2 (plakophilin 2) [NCBI Gene 5318] {aka ARVD9}
- **Diseases:** RV ectopy (MESH:D018497), PVCs (MESH:D018879), RV cardiomyopathy (MESH:C566255), ACM (MESH:D019571), akinesia (MESH:C537921), dyskinesia (MESH:D004409)
- **Chemicals:** gadolinium (MESH:D005682)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11341413/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11341413/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC11341413/full.md

---
Source: https://tomesphere.com/paper/PMC11341413